UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
August 9, 2006
HALOZYME THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Nevada
|
|
000-49616
|
|
88-0488686 |
| |
| (State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer |
| of incorporation)
|
|
File Number)
|
|
Identification No.) |
| |
|
|
| 11588 Sorrento Valley Road, Suite 17, San Diego, California
|
|
92121 |
|
|
|
|
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (858) 794-8889
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events.
On August 9, 2006 Halozyme Therapeutics, Inc. (the “Company”) announced that it sent notices
of redemption to warrant holders covering approximately 1.9 million shares of its common stock.
For 30 days following the notice, those warrant holders may exercise their warrants for $1.75 per
share. If all affected warrants are exercised, the Company will receive gross proceeds of
approximately $3.3 million. After 30 days, the Company may purchase any of the affected warrants
that are not exercised for $0.01 per share. The press release announcing this development is
attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
| |
|
|
| Exhibit |
|
Description |
99.1
|
|
Press Release issued by the Company on August 9, 2006. |